Danaher Corporation  

(Public, NYSE:DHR)   Watch this stock  
Find more results for DHR
84.92
+1.38 (1.65%)
Feb 12 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 83.77 - 84.96
52 week 81.25 - 97.62
Open 84.36
Vol / Avg. 2.58M/3.44M
Mkt cap 57.09B
P/E 22.93
Div/yield 0.14/0.64
EPS 3.70
Shares 686.80M
Beta 1.20
Inst. own 79%
May 6, 2016
Danaher Corp Annual Shareholders Meeting (Estimated) - 3:00PM EDT - Add to calendar
Apr 21, 2016
Q1 2016 Danaher Corp Earnings Release (Estimated) - 6:00AM EDT - Add to calendar
Jan 26, 2016
Q4 2015 Danaher Corp Earnings Call
Jan 26, 2016
Q4 2015 Danaher Corp Earnings Release
Jan 12, 2016
Danaher Corp at JPMorgan Healthcare Conference
Dec 16, 2015
Danaher Corp 2015 Investor & Analyst Meeting
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 12.49% 12.64%
Operating margin 16.63% 16.87%
EBITD margin - 21.98%
Return on average assets 6.02% 6.10%
Return on average equity 12.60% 11.04%
Employees 71,000 -
CDP Score - 12

Address

2200 Pennsylvania Ave NW Ste 800w
WASHINGTON, DC 20037-1731
United States - Map
+1-202-8280850 (Phone)
+1-202-8280860 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.

Officers and directors

Steven M. Rales Chairman of the Board
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel L. Comas Chief Financial Officer, Executive Vice President
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mitchell P. Rales Chairman of the Executive Committee, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William K. Daniel II Executive Vice President
Age: 50
Bio & Compensation  - Reuters
James A. Lico Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James H. Ditkoff Senior Vice President - Finance and Tax
Age: 68
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert S. Lutz Senior Vice President, Chief Accounting Officer
Bio & Compensation  - Reuters
Brian W Ellis Senior Vice President, General Counsel
Bio & Compensation  - Reuters
Angela S. Lalor Senior Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
William H. King Senior Vice President- Strategic Development
Age: 47
Bio & Compensation  - Reuters